Revolution Medicines schedules call on pancreatic cancer trial results

Go back to Revolution Medicines schedules call on pancreatic cancer trial results
(NASDAQ: RVMD) Delayed: 166.00 +3.01 (1.85%)
Previous Close $162.99    52 Week High
Open $162.32    52 Week Low
Day High $166.23    P/E N/A 
Day Low $162.15    EPS
Volume 367,238